Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Cancer Prostate Article
This is a selection made from among articles on Drug Treatment Cancer Prostate. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Dual Diagnosis Treatment Services are Ineffective for the GLBT Population in a Drug Rehab
By Jonathan Huttner
Most drug rehab services, including alcohol treatment programs, are geared towards serving a white, heterosexual, male, client. Unless great effort has been put into awareness training, developing knowledge about the experiences and circumstances of minority groups, and the establishment of programs to deal with the special needs of different groups of oppressed people, services will simply perpetuate institutional discrimination.
Gay Alcohol Treatment Programs Not Adequate
U.S. researchers Lohrenz et al (1978) found that 37% of homosexuals experienced discrimination from alcohol treatment program staff while Fifield, De Crescenzo & Latham (1975) discovered that 75% of homosexuals who are recovering from alcoholism believe that mainstream drug rehab and alcohol rehab program are not geared to treating homosexuals and do not provide an accepting and supportive environment. Because of discrimination homosexuals are less likely to attend an alcohol treatment program and drug addiction treatment program unless, that is, they are 'passing.' In this case, if the clinician does not bring up the subject, one of the major causes of their problems will be ignored. Rofes (1989) says: By ignoring the special problems that a lesbian alcoholic, for example, presents, an alcohol treatment program will be doing a service to no one. Their alcoholism treatment of the individual will be less than adequate and may tend to intensify the woman's feelings of isolation and 'difference.' Only by bringing the issue into the open and addressing the woman's lesbianism as an aspect of her life which she needs to feel positively about, will the program be truly effective.
Avoiding Coming Out
Shernoff & Finnegan (1991) discuss the case of a lesbian who is hiding her sexuality, then stress: It is the responsibility of each alcoholism treatment counselor to take the lead in this area the same way alcohol treatment counselors routinely question early family history, dynamics of shame, denial and spirituality. By omitting questions about sexual orientation, or the more subtle questions about sexual or affectional feelings or fantasies for a person of the same sex, the counselor is not obtaining information about all the possible contributing factors for achieving and maintaining sobriety. While Hellman et al (1989) note: Therapists may fear causing anxiety by asking patients about sexual orientation because of discomfort with the subject. However, this questioning can be essential in helping to overcome the secrecy and denial that are hall marks of the struggle with both alcoholism and homosexuality. Of course, if a worker is ignorant about homosexuality s/he is likely to make the situation worse:
Problems Faced In Gay Alcohol Treatment Programs
American surveys, referred to by Hellman et al (1989), reveal a list of complaints about mainstream provision ranging from
· heterosexual bias in alcoholism treatment and evaluation (including either focusing primarily on sexual orientation when inappropriate or ignoring important factors linked with sexuality)
· ignorance about lesbian/gay issues and discomfort at approaching matters of sexuality
· ignorance about the inter-relation of homosexuality and alcohol abuse
. Neisen & Sandall (1990) worked at a program designed to offer alcohol treatment to chemically dependent lesbians and gays. They list their clients' experiences of non-gay drug rehab or non gay alcohol rehab, which include:
some were forced to disclose their sexual orientation
as soon as their sexuality was known, some were discharged
some said that after disclosure the alcohol treatment they received was different due to an atmosphere of condemnation
some feared that if their sexual orientation was known about this would receive more emphasis than their chemical dependency
some addiction treatment programs were not happy having their partner attend a family program.
Citing Morales & Graves (1983) and Hellman, Stanton, Lee, Tytun and Vachon (1989), O'Hanlan (1996) notes:
· the majority of detox and drug rehabilitation and alcohol rehab programs were insensitive to issues of sexual orientation and did not, generally, encourage its disclosure
· homophobia limits the success of recovery and alcohol treatment for lesbian substance abusers (Hall, 1990; de Monteflores, 1986)
· failure to acknowledge sexual orientation makes relapse more likely (Cabaj, 1992)
· lesbians were more likely to attend alcohol treatment program services which address lesbian social issues and provide lesbian counsellors (Hall,1986, 1990, 1992, 1993, 1994; Morales & Graves, 1983).
Family Treatment In Gay Alcohol Treatment Programs
Inclusion of families in addiction treatment and alcohol rehab program is now an acceptable way of supporting those coming off alcohol dependency (Nardi, 1982; Shernoff & Finnegan, 1991). This would be problematic for the homosexual client, partly because many will have been rejected by their families and those families who do not reject their offspring rarely want to discuss anything connected with homosexuality. Yet it is the ignorance and lack of acceptance of families which is one of the main reasons why homosexuals are vulnerable to alcohol abuse and drug abuse. Alcoholism treatment does work!
A gay alcohol treatment program, drug rehab or gay friendly dual diagnosis treatment program, can be found at a web site located at www.lakeviewhealth.com or you can call the dual diagnosis national helpline at 1-800-511-9225 to locate a dual diagnosis treatment program in your local area.
Jonathan Huttner is a principal with Lakeview Health Systems, which treats drug addiction and alcohol addiction in a gay friendly environment. Lakeview also operates a nationally recognized dual diagnosis treatment program.
Article Source: http://EzineArticles.com/?expert=Jonathan_Huttner
http://EzineArticles.com/?Dual-Diagnosis-Treatment-Services-are-Ineffective-for-the-GLBT-Population-in-a-Drug-Rehab&id=385778
Drug Treatment Cancer Prostate Specific links
Drug Treatment Cancer Prostate News
Trial Supports Earlier Use of a Prostate Cancer Drug - New York Times
 The Guardian | Trial Supports Earlier Use of a Prostate Cancer Drug New York Times A new drug used to treat advanced prostate cancer may also help men if used early in the course of the disease, before an operation, researchers reported Wednesday. In a small clinical trial, six months of treatment with the drug, Johnson & Johnson's ... Advanced Prostate Cancer Drug May Help at Earlier Stage J&J drug shows promise in high-risk prostate cancer Study Shows J&J's Zytiga Can Eliminate Some Prostate Tumors; Drug Combinations ... |
Anti-psychotic drug kills cancer stem cells without side-effects: Study - Zee News
 Zee News | Anti-psychotic drug kills cancer stem cells without side-effects: Study Zee News Vancouver: A team of Canadian scientists have discovered that thioridazine, a drug used to treat psychotic disorder, could successfully kill cancer stem cells in humans without the toxic side-effects on normal cells. The research, published Thursday in ... |
Eden Prairie firm wins approval to sell prostate imaging technology - Minneapolis Star Tribune
 Minneapolis Star Tribune | Eden Prairie firm wins approval to sell prostate imaging technology Minneapolis Star Tribune The ProUroScan prostate system got FDA approval on April 27 and utilizing high-resolution scans, could help doctos better identify prostate cancer. For men who want to know if those frequent nighttime visits to the bathroom might indicate prostate ... |
New prostate cancer treatment rejected for use in Ireland - Newstalk 106-108 fm
New prostate cancer treatment rejected for use in Ireland Newstalk 106-108 fm Zytiga, which has been dubbed a `wonder drug', can extend the lives of late-stage prostate cancer sufferers. According to a report in the Sunday Business Post, the drug was approved for use in Britain earlier this month. However, the National Centre ... |
J&J drug shows promise in high-risk prostate cancer - Chicago Tribune
 Daily Mail | J&J drug shows promise in high-risk prostate cancer Chicago Tribune (Reuters) - Adding Johnson & Johnson's advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six ... Britain to fund prostate cancer pill in U-turn J&J's Zytiga Helps Eliminate Early-Stage Prostate Cancer Prostate cancer drug Abiraterone set for approval in England and Wales but not ... |
AM Vitals: New Recommendation on Prostate Cancer Screening - Wall Street Journal (blog)
 TIME | AM Vitals: New Recommendation on Prostate Cancer Screening Wall Street Journal (blog) ... Prostate Test, Panel Says (WSJ): The US Preventive Services Task Force recommended a “D” grade for prostate-specific-antigen, or PSA, testing which has been widely used for almost two decades to screen men for prostate cancer. Osteoporosis Drugs ... Why People Stick with Cancer Screening, Even When It Causes Harm Prostate cancer and the PSA test: It's hard to understand risk Researcher Alan Cassels scrutinizes medical screening tests |
Dendreon falls as analyst says J&J and Medivation prostate cancer drugs will ... - Minneapolis Star Tribune
Dendreon falls as analyst says J&J and Medivation prostate cancer drugs will ... Minneapolis Star Tribune Article by: AP NEW YORK - Shares of Dendreon Corp. sank Wednesday after a Jefferies & Co. analyst said the company's prostate cancer therapy Provenge will be eclipsed by two newer competitors. THE SPARK: Analyst Biren Amin started covering Dendreon ... Rivals to Hurt Provenge Sales |
NHS 'OK' for prostate cancer drug Zytiga - Nursing Times
 PR Web | NHS 'OK' for prostate cancer drug Zytiga Nursing Times “NHS ban on pill to treat prostate cancer is lifted,” the Daily Express has said, while the Daily Mail has warned that a “prostate cancer wonder drug” was set for approval “south of border but turned down by Scotland”. The stories focus on the fact ... UK's NICE Gives Thumbs Up to New Prostate Cancer Treatment Following Price Drop |
Medivation and Astellas Announce Submission of New Drug Application for ... - MarketWatch (press release)
Medivation and Astellas Announce Submission of New Drug Application for ... MarketWatch (press release) The compound has been studied in patients with castration-resistant prostate cancer who have received docetaxel therapy. Pursuant to the Prescription Drug User Fee Act (PDUFA), the FDA is expected to determine within 60 days whether to accept the ... Medivation Files Enzalutamide NDA Astellas/Medivation file prostate cancer drug in USA Medivation Submits NDA For Enzalutamide |
New Drug Kills Cancer Cells Without Toxic Effects - RedOrbit
 RedOrbit | New Drug Kills Cancer Cells Without Toxic Effects RedOrbit A group of researchers from McMaster University have found a new drug that can kill cancer stem cells in humans while avoiding the toxic side effects of other traditional cancer treatments. Over the past 15 years, researchers have thought that stem ... Schizophrenia drug may fight cancer 'New Drug For Destroying Human Cancer Stem Cells' Researchers discover drug destroys human cancer stem cells but not healthy ones |